XeroBurn Burn Gel

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: XeroBurn Burn Gel
Generic name: LIDOCAINE HYDROCHLORIDE
Manufacturer: Dynarex Corporation
Product type: HUMAN OTC DRUG
SPL set ID: 58985046-ca9c-12be-e053-2991aa0abe72
SPL ID: 303feeb7-93b4-5920-e063-6394a90a0caf
Version: 7
Effective date: 2025-03-13
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:43:15

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 23 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		XeroBurn Burn Gel	openfda.brand_name
generic name		LIDOCAINE HYDROCHLORIDE	openfda.generic_name
manufacturer name		Dynarex Corporation	openfda.manufacturer_name
ndc	package	67777-129-01	openfda.package_ndc
ndc	package	67777-129-02	openfda.package_ndc
ndc	package	67777-129-00	openfda.package_ndc
ndc	package	67777-129-09	openfda.package_ndc
ndc	package	67777-129-03	openfda.package_ndc
ndc	package	67777-129-11	openfda.package_ndc
ndc	package	67777-129-10	openfda.package_ndc
ndc	product	67777-129	openfda.product_ndc
ndc11	package	67777012910	derived:openfda.package_ndc
ndc11	package	67777012902	derived:openfda.package_ndc
ndc11	package	67777012900	derived:openfda.package_ndc
ndc11	package	67777012903	derived:openfda.package_ndc
ndc11	package	67777012901	derived:openfda.package_ndc
ndc11	package	67777012911	derived:openfda.package_ndc
ndc11	package	67777012909	derived:openfda.package_ndc
rxcui		1011852	openfda.rxcui
spl id		303feeb7-93b4-5920-e063-6394a90a0caf	id
spl set id		58985046-ca9c-12be-e053-2991aa0abe72	set_id
unii		V13007Z41A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For External Use Only Do not use ■ On wounds or damaged skin ■ In large quantities, particularly over raw surfaces or blistered areas When using this product ■ Avoid contact with the eyes ■ Do not bandage tightly Stop use and ask a doctor if ■ Condition worsens ■ Symptoms persist for more than 7 days ■ Symptoms clear up and occur again within a few days Keep out of reach of children If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.